Categories
Dr. Lal Path Labs Ltd. — Updates, 30-04-2026: General Updates
30-04-2026 · 03:41 pm
Board approved Q4 & FY26 financial results, with FY26 consolidated revenue at ₹2,762.9 Cr and profit at ₹509.8 Cr. A final dividend of ₹4/share was declared. Company will acquire Shahbazkers Diagnostic (up to ₹20 Cr) to boost Mumbai presence and incorporate a WOS in Dubai for international expansion.
No comments yet. Be the first to comment!